Home

Diseases associated with low levels of 25-D

According to the Marshall PathogenesisA description for how chronic inflammatory diseases originate and develop., chronic inflammatory disease is caused by a microbiotaThe bacterial community which causes chronic diseases - one which almost certainly includes multiple species and bacterial forms. of pathogens which interfere with proper functioning of the innate immune system. Patients suffering from inflammatory diseases have been shown to have lower than normal levels of 25-hydroxyvitamin D, and there are at least several reasons why bacterial pathogens generate this response.

A full understanding of vitamin D metabolism supports the conclusion that elevated 1,25-D and depressed 25-D are a result rather than a cause of the inflammatory process.

Lower than normal levels of 25-D have been independently associated both with all-cause mortality1) 2) and a number of chronic inflammatory diseases. The following selection of diseases (and patient groups) have been observed to display the hallmarks of this kind of dysregulated vitamin D metabolism.

Anomalies

Both lower and higher levels of 25-D are associated with increased mortality. This 2012 study analyzed blood serum from 247,574 Danish subjects and found a reverse J-curve for mortality.
  • mortality in the Danish population – A 2012 study of 247,574 subjects found that both lower and higher levels of 25-D were associated with an increased likelihood of mortality (right).68)
  • U-shaped relationship between vitamin D levels and long-term outcome. – In a 5 year follow-up of survivors of acute myocardial infarction patients with vitamin D<10ng/mL and >30ng/mL had higher mortality rate than those with intermediate values. 69)
  • risk of breast cancer – In a 2011 study of nurses who were predominantly premenopausal, circulating 25-D levels were not significantly associated with breast cancer risk.
  • risk of prostate cancer – In a 2008 nested case-control study appearing in Journal of the National Cancer Institute, Ahn et al. found that patients with the lowest levels of 25-D also had the lowest risk of prostate cancer.70)
  • risk of pancreatic cancer – Patients with the highest levels of 25-D were at greatest risk of pancreatic cancer.71)
  • some rarer cancers72) – non-Hodgkin lymphoma or cancers of the endometrium, esophagus, stomach, kidney, ovary and pancreas
  • cancer mortality – A 2010 longitudinal study found that both high and low concentrations of plasma 25(OH)D were associated with elevated risks of overall and cancer mortality, and low concentrations are associated with cardiovascular mortality.73)
  • neonatal vitamin D status and risk of schizophrenia – Danish neonates with the highest measurable levels of 25-D had a two-fold elevated risk of developing schizoprhenia. Based on this analysis, the population-attributable fraction associated with neonatal vitamin D status was 44%. The relationship was not explained by a wide range of potential confounding or interacting variables.74) This study is consistent with the explanation that higher rates of disease were caused by the immunosuppressive effects of heavy supplementation with vitamin D.
  • atrial fibrillation – According to results shared at a 2012 conference, patients with 25-D levels above 100 nanograms per 100ml, were 2.5 times more likely to have atrial fibrillation as those with more moderate levels (41-80ng/100ml).
  • atherosclerosis in African Americans – Vitamin D is widely used to treat patients with osteoporosis and/or low vitamin D levels based on a medically accepted normal range. This “normal” range is typically applied to all race groups, although it was established predominantly in whites. It is thought that as low vitamin D levels rise to the normal range with supplementation, protection from bone and heart disease (atherosclerosis) may increase, as well. Blacks generally have lower vitamin D levels than whites, partly because their darker skin pigmentation limits the amount of the vitamin produced by sunlight. “Despite” these lower vitamin D levels and dietary calcium ingestion, blacks naturally experience lower rates of osteoporosis and have far less calcium in their arteries. Studies further reveal that black patients with diabetes have half the rate of heart attack as whites, when provided equal access to health care. A 2010 study (explained here) determined the relationship between circulating vitamin D levels and arterial calcium in 340 black men and women with type 2 diabetes.75) The team concluded that higher circulating levels of 25-D in blacks were associated with higher levels of calcified atherosclerotic plaque.

Notes and comments

Sallie Q 09.16.2016 added 2016 report on U-shape curve high up on list of anomalies

References

1)
25-hydroxyvitamin D levels and the risk of mortality in the general population.
Melamed ML, Michos ED, Post W, Astor B
Arch Intern Med168p1629-37(2008 Aug 11)
2) , 21)
Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults.
Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR, Guralnik JM, Ferrucci L
Eur J Clin Nutr64p203-9(2010 Feb)
3)
An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men.
Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamäki H, Ylikomi T
Am J Clin Nutr86p714-7(2007 Sep)
4) , 22)
Celiac disease and the endocrinologist: a diagnostic opportunity.
Fisher AH, Lomasky SJ, Fisher MJ, Oppenheim YL
Endocr Pract14p381-8(2008 Apr)
5)
Association of facial skin aging and vitamin D levels in middle-aged white women.
Chang AL, Fu T, Amir O, Tang JY
Cancer Causes Controlp(2010 Sep 30)
6) , 35) , 62)
Vitamin D in schizophrenia, major depression and alcoholism.
Schneider B, Weber B, Frensch A, Stein J, Fritz J
J Neural Transm107p839-42(2000)
7)
Serum 25-hydroxyvitamin D and IgE - a significant but nonlinear relationship.
Hyppönen E, Berry DJ, Wjst M, Power C
Allergy64p613-620(2009 Apr)
8) , 10)
Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica.
Brehm JM, Celedón JC, Soto-Quiros ME, Avila L, Hunninghake GM, Forno E, Laskey D, Sylvia JS, Hollis BW, Weiss ST, Litonjua AA
Am J Respir Crit Care Med179p765-71(2009 May 1)
9) , 60)
Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease.
Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V
Arch Neurol65p1348-52(2008 Oct)
11)
Vitamin D deficiency masquerading as metastatic cancer: a case series.
Khokhar JS, Brett AS, Desai A
Am J Med Sci337p245-7(2009 Apr)
12)
Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer.
Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N
J Clin Oncol27p3757-63(2009 Aug 10)
13)
Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk.
Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H
Aliment Pharmacol Ther30p113-25(2009 Jul 1)
14)
The role of Vitamin D3 metabolism in prostate cancer.
Lou YR, Qiao S, Talonpoika R, Syvälä H, Tuohimaa P
J Steroid Biochem Mol Biol92p317-25(2004 Nov)
15) , 16) , 17)
Epidemiology of disease risks in relation to vitamin D insufficiency.
Grant WB
Prog Biophys Mol Biol92p65-79(2006 Sep)
18)
25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients.
Matias PJ, Ferreira C, Jorge C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A
Nephrol Dial Transplant24p611-8(2009 Feb)
19)
Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?
Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF
J Am Coll Cardiol52p1949-56(2008 Dec 9)
23)
Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial.
Arvold DS, Odean MJ, Dornfeld MP, Regal RR, Arvold JG, Karwoski GC, Mast DJ, Sanford PB, Sjoberg RJ
Endocr Pract15p203-12(2009 May-Jun)
24)
Micronutrient status in children with cerebral palsy.
Hillesund E, Skranes J, Trygg KU, Bøhmer T
Acta Paediatr96p1195-8(2007 Aug)
25)
Prevalence of Vitamin D Deficiency in Chronic Liver Disease.
Arteh J, Narra S, Nair S
Dig Dis Scip(2009 Dec 4)
26)
Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D.
Franco CB, Paz-Filho G, Gomes PE, Nascimento VB, Kulak CA, Boguszewski CL, Borba VZ
Osteoporos Int20p1881-7(2009 Nov)
27)
Vitamin D is associated with cognitive function in elders receiving home health services.
Buell JS, Scott TM, Dawson-Hughes B, Dallal GE, Rosenberg IH, Folstein MF, Tucker KL
J Gerontol A Biol Sci Med Sci64p888-95(2009 Aug)
28)
Vitamin D and cognitive performance in adults: a systematic review.
Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW, Beauchet O
Eur J Neurol16p1083-9(2009 Oct)
29)
Vitamin D insufficiency in congestive heart failure: why and what to do about it?
Zittermann A, Schleithoff SS, Koerfer R
Heart Fail Rev11p25-33(2006 Mar)
30)
Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases.
Hagaman JT, Panos RJ, McCormack FX, Thakar CV, Wikenheiser-Brokamp KA, Shipley RT, Kinder BW
Chestp(2010 Aug 5)
31)
The frequency of vitamin D deficiency in adults with Crohn's disease.
Siffledeen JS, Siminoski K, Steinhart H, Greenberg G, Fedorak RN
Can J Gastroenterol17p473-8(2003 Aug)
32)
Vitamin D in infants with cystic fibrosis diagnosed by newborn screening.
Neville LA, Ranganathan SC
J Paediatr Child Health45p36-41(2009 Jan-Feb)
33)
Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese.
Pan A, Lu L, Franco OH, Yu Z, Li H, Lin X
J Affect Disord118p240-3(2009 Nov)
34)
Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season.
Nanri A, Mizoue T, Matsushita Y, Poudel-Tandukar K, Sato M, Ohta M, Mishima N
Eur J Clin Nutr63p1444-7(2009 Dec)
36)
Vitamin D and type 2 diabetes: Is there a link?
Chowdhury TA, Boucher BJ, Hitman GA
Prim Care Diabetes3p115-6(2009 May)
37)
25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity.
Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A
Obesity (Silver Spring)18p1906-10(2010 Oct)
38)
Significant vitamin D deficiency in youth with type 1 diabetes mellitus.
Svoren BM, Volkening LK, Wood JR, Laffel LM
J Pediatr154p132-4(2009 Jan)
39)
Vitamin D deficiency in older men.
Orwoll E, Nielson CM, Marshall LM, Lambert L, Holton KF, Hoffman AR, Barrett-Connor E, Shikany JM, Dam T, Cauley JA
J Clin Endocrinol Metab94p1214-22(2009 Apr)
40)
Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons.
Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P
J Clin Endocrinol Metab94p1244-50(2009 Apr)
42)
High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease.
Yamashita H, Noguchi S, Takatsu K, Koike E, Murakami T, Watanabe S, Uchino S, Yamashita H, Kawamoto H
Endocr J48p63-9(2001 Feb)
43)
Hypovitaminosis D in chronic kidney disease.
Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, Takasu J, Adler S, Norris K
Clin J Am Soc Nephrol3p1144-51(2008 Jul)
44)
Vitamin D Biology in Heart Failure: Molecular Mechanisms and Systematic Review.
Meems LM, van der Harst P, van Gilst WH, de Boer RA
Curr Drug Targetsp(2010 Aug 27)
45)
High frequency of vitamin D deficiency in ambulatory HIV-Positive patients.
Rodríguez M, Daniels B, Gunawardene S, Robbins GK
AIDS Res Hum Retroviruses25p9-14(2009 Jan)
46)
Vitamin D status in children and young adults with inflammatory bowel disease.
Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih MC, Grand RJ
Pediatrics118p1950-61(2006 Nov)
47)
The link between vitamin D deficiency and systemic lupus erythematosus.
Kamen DL, Aranow C
Curr Rheumatol Rep10p273-80(2008 Aug)
48)
The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus.
Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM, Collins CE, Gilkeson GS, Diamond B, Hardin JA
PLoS One5pe9193(2010 Feb 16)
49)
Kevin C. Maki, Martyn R. Rubin, Les G. Wong, Jamie F. McManus, Christopher D. Jensen, John W. Marshall, Andrea Lawless. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women/ 21 July 2009 (Article in Press DOI: 10.1016/j.jacl.2009.07.003).
51)
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R
Mult Scler14p1220-4(2008 Nov)
52)
25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.
Giovannucci E, Liu Y, Hollis BW, Rimm EB
Arch Intern Med168p1174-80(2008 Jun 9)
53)
Association between serum 25-hydroxyvitamin D levels and body composition in postmenopausal women: the postmenopausal Health Study.
Moschonis G, Tanagra S, Koutsikas K, Nikolaidou A, Androutsos O, Manios Y
Menopause16p701-7(2009 Jul-Aug)
54)
Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women.
Kremer R, Campbell PP, Reinhardt T, Gilsanz V
J Clin Endocrinol Metab94p67-73(2009 Jan)
55)
Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study.
Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G
Eur J Nutr49p401-7(2010 Oct)
56)
Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures Research Group.
Lane NE, Gore LR, Cummings SR, Hochberg MC, Scott JC, Williams EN, Nevitt MC
Arthritis Rheum42p854-60(1999 May)
57)
Vitamin D deficiency and low bone status in adult female garment factory workers in Bangladesh.
Islam MZ, Shamim AA, Kemi V, Nevanlinna A, Akhtaruzzaman M, Laaksonen M, Jehan AH, Jahan K, Khan HU, Lamberg-Allardt C
Br J Nutr99p1322-9(2008 Jun)
58)
Vitamin D and chronic widespread pain in a white middle-aged British population: evidence from a cross-sectional population survey.
Atherton K, Berry DJ, Parsons T, Macfarlane GJ, Power C, Hyppönen E
Ann Rheum Dis68p817-22(2009 Jun)
59)
Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain.
Turner MK, Hooten WM, Schmidt JE, Kerkvliet JL, Townsend CO, Bruce BK
Pain Med9p979-84(2008 Nov)
63)
Lee DM, Tajar A et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. Journal of Neurology, Neurosurgery, and Psychiatry 2009;80:722-729.
64)
Low vitamin d levels predict stroke in patients referred to coronary angiography.
Pilz S, Dobnig H, Fischer JE, Wellnitz B, Seelhorst U, Boehm BO, März W
Stroke39p2611-3(2008 Sep)
65)
Vitamin D deficiency and insufficiency in children with tuberculosis.
Williams B, Williams AJ, Anderson ST
Pediatr Infect Dis J27p941-2(2008 Oct)
66)
Vitamin D deficiency in undifferentiated connective tissue disease.
Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Zeher M, Szegedi G, Bodolay E
Arthritis Res Ther10pR123(2008)
68)
A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice: The CopD Study.
Durup D, Jørgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B
J Clin Endocrinol Metab97p2644-52(2012 Aug)
69)
U-shaped relationship between vitamin D levels and long-term outcome in large cohort of survivors of acute myocardial infarction.
Aleksova A, Beltrami AP, Belfiore R, Barbati G, Di Nucci M, Scapol S, De Paris V, Carriere C, Sinagra G
Int J Cardiol223p962-966(2016 Aug 24)
70)
Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N, Horst RL, Hollis BW, Huang WY, Shikany JM, Hayes RB
J Natl Cancer Inst100p796-804(2008 Jun 4)
71) , 72)
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, Hartge P, Hartmuller V, Harvey C, Hayes RB, Horst RL, Koenig KL, Kolonel LN, Laden F, McCullough ML, Parisi D, Purdue MP, Shu XO, Snyder K, Stolzenberg-Solomon RZ, Tworoger SS, Varanasi A, Virtamo J, Wilkens LR, Xiang YB, Yu K, Zeleniuch-Jacquotte A, Zheng W, Abnet CC, Albanes D, Bertrand K, Weinstein SJ
Am J Epidemiol172p10-20(2010 Jul 1)
73)
Plasma vitamin D and mortality in older men: a community-based prospective cohort study.
Michaëlsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundström J, Berglund L, Arnlöv J, Hellman P, Blomhoff R, Wolk A, Garmo H, Holmberg L, Melhus H
Am J Clin Nutrp(2010 Aug 18)
74)
Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study.
McGrath JJ, Eyles DW, Pedersen CB, Anderson C, Ko P, Burne TH, Norgaard-Pedersen B, Hougaard DM, Mortensen PB
Arch Gen Psychiatry67p889-94(2010 Sep)
75)
Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans.
Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC, Gordon EJ, Xu J, Langefeld CD, Divers J
J Clin Endocrinol Metab95p1076-83(2010 Mar)
home/pathogenesis/vitamind/low25d.txt · Last modified: 10.27.2018 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.